1 Introduction to Research & Analysis Reports

　1.1 Artemisinin Derivatives Market Definition

　1.2 Market Segments

　　1.2.1 Segment by Type

　　1.2.2 Segment by Application

　1.3 China Artemisinin Derivatives Market Overview

　1.4 Methodology & Sources of Information

　　1.4.1 Research Methodology

　　1.4.2 Research Process

　　1.4.3 Base Year

2 China Artemisinin Derivatives Overall Market Size

　2.1 China Artemisinin Derivatives Market Size: 2021 VS 2027

　2.2 China Artemisinin Derivatives Revenue, Prospects & Forecasts: 2016-2027

　2.3 China Artemisinin Derivatives Sales: 2016-2027

3 Company Landscape

　3.1 Top Artemisinin Derivatives Players in China Market

　3.2 Top China Artemisinin Derivatives Companies Ranked by Revenue

　3.3 China Artemisinin Derivatives Revenue by Companies

　3.4 China Artemisinin Derivatives Sales by Companies

　3.5 China Artemisinin Derivatives Price by Manufacturer (2016-2021)

　3.6 Top 3 and Top 5 Artemisinin Derivatives Companies in China Market, by Revenue in 2020

　3.7 Manufacturers Artemisinin Derivatives Product Type

　3.8 Tier 1, Tier 2 and Tier 3 Artemisinin Derivatives Players in China Market

詳情：http://www.htout.com/0/93/China-Artemisinin-Derivatives-Market-Analysis-and-Trends-Report-2021-2027.html

　　3.8.1 List of Tier 1 Artemisinin Derivatives Companies in China

　　3.8.2 List of Tier 2 and Tier 3 Artemisinin Derivatives Companies in China

4 Sights by Type

　4.1 Overview

　　4.1.1 By Type - China Artemisinin Derivatives Market Size Markets, 2021 & 2027

　　4.1.2 Dihydroartemisinin

　　4.1.3 Artemisunate

　　4.1.4 Others

　4.2 By Type - China Artemisinin Derivatives Revenue & Forecasts

　　4.2.1 By Type - China Artemisinin Derivatives Revenue, 2016-2021

　　4.2.2 By Type - China Artemisinin Derivatives Revenue, 2022-2027

　　4.2.3 By Type - China Artemisinin Derivatives Revenue Market Share, 2016-2027

　4.3 By Type - China Artemisinin Derivatives Sales & Forecasts

　　4.3.1 By Type - China Artemisinin Derivatives Sales, 2016-2021

　　4.3.2 By Type - China Artemisinin Derivatives Sales, 2022-2027

　　4.3.3 By Type - China Artemisinin Derivatives Sales Market Share, 2016-2027

　4.4 By Type - China Artemisinin Derivatives Price (Manufacturers Selling Prices), 2016-2027

5 Sights by Application

　5.1 Overview

　　5.1.1 By Application - China Artemisinin Derivatives Market Size, 2021 & 2027

　　5.1.2 Malaria Treatment

　　5.1.3 Scientific Research

　　5.1.4 Others

　5.2 By Application - China Artemisinin Derivatives Revenue & Forecasts

　　5.2.1 By Application - China Artemisinin Derivatives Revenue, 2016-2021

　　5.2.2 By Application - China Artemisinin Derivatives Revenue, 2022-2027

　　5.2.3 By Application - China Artemisinin Derivatives Revenue Market Share, 2016-2027

　5.3 By Application - China Artemisinin Derivatives Sales & Forecasts

　　5.3.1 By Application - China Artemisinin Derivatives Sales, 2016-2021

　　5.3.2 By Application - China Artemisinin Derivatives Sales, 2022-2027

　　5.3.3 By Application - China Artemisinin Derivatives Sales Market Share, 2016-2027

　5.4 By Application - China Artemisinin Derivatives Price (Manufacturers Selling Prices), 2016-2027

6 Manufacturers & Brands Profiles

　6.1 Sanofi

　　6.1.1 Sanofi Corporation Information

　　6.1.2 Sanofi Overview

　　6.1.3 Sanofi Artemisinin Derivatives Sales and Revenue in China Market (2016-2021)

　　6.1.4 Sanofi Artemisinin Derivatives Product Description

　　6.1.5 Sanofi Recent Developments

　6.2 KPC Pharmaceuticals

　　6.2.1 KPC Pharmaceuticals Corporation Information

　　6.2.2 KPC Pharmaceuticals Overview

　　6.2.3 KPC Pharmaceuticals Artemisinin Derivatives Sales and Revenue in China Market (2016-2021)

　　6.2.4 KPC Pharmaceuticals Artemisinin Derivatives Product Description

　　6.2.5 KPC Pharmaceuticals Recent Developments

　6.3 Guangxi Xiancaotang Pharmaceutical

中國青蒿素衍生品市場分析和趨勢報告2021-2027

　　6.3.1 Guangxi Xiancaotang Pharmaceutical Corporation Information

　　6.3.2 Guangxi Xiancaotang Pharmaceutical Overview

　　6.3.3 Guangxi Xiancaotang Pharmaceutical Artemisinin Derivatives Sales and Revenue in China Market (2016-2021)

　　6.3.4 Guangxi Xiancaotang Pharmaceutical Artemisinin Derivatives Product Description

　　6.3.5 Guangxi Xiancaotang Pharmaceutical Recent Developments

　6.4 Guilin Pharmaceutical

　　6.4.1 Guilin Pharmaceutical Corporation Information

　　6.4.2 Guilin Pharmaceutical Overview

　　6.4.3 Guilin Pharmaceutical Artemisinin Derivatives Sales and Revenue in China Market (2016-2021)

　　6.4.4 Guilin Pharmaceutical Artemisinin Derivatives Product Description

　　6.4.5 Guilin Pharmaceutical Recent Developments

　6.5 Kerui Nanhai Pharmaceutical

　　6.5.1 Kerui Nanhai Pharmaceutical Corporation Information

　　6.5.2 Kerui Nanhai Pharmaceutical Overview

　　6.5.3 Kerui Nanhai Pharmaceutical Artemisinin Derivatives Sales and Revenue in China Market (2016-2021)

　　6.5.4 Kerui Nanhai Pharmaceutical Artemisinin Derivatives Product Description

　　6.5.5 Kerui Nanhai Pharmaceutical Recent Developments

　6.6 Shanghai Natural Bio-engineering Co

　　6.6.1 Shanghai Natural Bio-engineering Co Corporation Information

　　6.6.2 Shanghai Natural Bio-engineering Co Overview

　　6.6.3 Shanghai Natural Bio-engineering Co Artemisinin Derivatives Sales and Revenue in China Market (2016-2021)

　　6.6.4 Shanghai Natural Bio-engineering Co Artemisinin Derivatives Product Description

　　6.6.5 Shanghai Natural Bio-engineering Co Recent Developments

　6.7 Novanat Bioresource

　　6.7.1 Novanat Bioresource Corporation Information

　　6.7.2 Novanat Bioresource Overview

　　6.7.3 Novanat Bioresource Artemisinin Derivatives Sales and Revenue in China Market (2016-2021)

　　6.7.4 Novanat Bioresource Artemisinin Derivatives Product Description

　　6.7.5 Novanat Bioresource Recent Developments

　6.8 Botanical Extracts EPZ Ltd

　　6.8.1 Botanical Extracts EPZ Ltd Corporation Information

　　6.8.2 Botanical Extracts EPZ Ltd Overview

　　6.8.3 Botanical Extracts EPZ Ltd Artemisinin Derivatives Sales and Revenue in China Market (2016-2021)

　　6.8.4 Botanical Extracts EPZ Ltd Artemisinin Derivatives Product Description

　　6.8.5 Botanical Extracts EPZ Ltd Recent Developments

7 China Artemisinin Derivatives Production Capacity, Analysis

　7.1 China Artemisinin Derivatives Production Capacity, 2016-2027

　7.2 Artemisinin Derivatives Production Capacity of Key Manufacturers in China Market

8 Key Market Trends, Opportunity, Drivers and Restraints

　8.1 Market Opportunities & Trends

　8.2 Market Drivers

　8.3 Market Restraints

9 Artemisinin Derivatives Supply Chain Analysis

　9.1 Artemisinin Derivatives Industry Value Chain

　9.2 Artemisinin Derivatives Upstream Market

　9.3 Artemisinin Derivatives Downstream and Clients

中國青蒿素衍生品市場分析和趨勢報告2021-2027

　9.4 Marketing Channels Analysis

　　9.4.1 Marketing Channels

　　9.4.2 Artemisinin Derivatives Distributors and Sales Agents in China Market

10 Conclusion

11 Appendix

　11.1 Note

　11.2 Examples of Clients

　11.3 Author Details

　11.4 Disclaimer

List of Tables

　Table 1. Key Players of Artemisinin Derivatives in China Market

　Table 2. Top Artemisinin Derivatives Players in China Market, Ranking by Revenue (2019)

　Table 3. China Artemisinin Derivatives Revenue by Companies, (US$, Mn), 2016-2021

　Table 4. China Artemisinin Derivatives Revenue Share by Companies, 2016-2021

　Table 5. China Artemisinin Derivatives Sales by Companies, (K MT), 2016-2021

　Table 6. China Artemisinin Derivatives Sales Share by Companies, 2016-2021

　Table 7. Key Manufacturers Artemisinin Derivatives Price (2016-2021) & (USD/MT)

　Table 8. Manufacturers Artemisinin Derivatives Product Type

　Table 9. List of Tier 1 Artemisinin Derivatives Companies, Revenue (US$, Mn) in 2020 and Market Share

　Table 10. List of Tier 2 and Tier 3 Artemisinin Derivatives Companies, Revenue (US$, Mn) in 2020 and Market Share

　Table 11. Major Manufacturers of Dihydroartemisinin

　Table 12. Major Manufacturers of Artemisunate

　Table 13. By Type – China Artemisinin Derivatives Revenue, (US$, Mn), 2021 & 2027

　Table 14. By Type - China Artemisinin Derivatives Revenue (US$, Mn), 2016-2021

　Table 15. By Type - China Artemisinin Derivatives Revenue (US$, Mn), 2022-2027

　Table 16. By Type - China Artemisinin Derivatives Sales (K MT), 2016-2021

　Table 17. By Type - China Artemisinin Derivatives Sales (K MT), 2022-2027

　Table 18. By Application – China Artemisinin Derivatives Revenue, (US$, Mn), 2021 VS 2027

　Table 19. By Application - China Artemisinin Derivatives Revenue (US$, Mn), 2016-2021

　Table 20. By Application - China Artemisinin Derivatives Revenue (US$, Mn), 2022-2027

　Table 21. By Application - China Artemisinin Derivatives Sales (K MT), 2016-2021

　Table 22. By Application - China Artemisinin Derivatives Sales (K MT), 2022-2027

　Table 23. Sanofi Corporation Information

　Table 24. Sanofi Description and Major Businesses

　Table 25. Sanofi Artemisinin Derivatives Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)

　Table 26. Sanofi Artemisinin Derivatives Product

　Table 27. Sanofi Recent Developments

　Table 28. KPC Pharmaceuticals Corporation Information

　Table 29. KPC Pharmaceuticals Description and Major Businesses

　Table 30. KPC Pharmaceuticals Artemisinin Derivatives Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)

　Table 31. KPC Pharmaceuticals Artemisinin Derivatives Product

　Table 32. KPC Pharmaceuticals Recent Developments

　Table 33. Guangxi Xiancaotang Pharmaceutical Corporation Information

　Table 34. Guangxi Xiancaotang Pharmaceutical Description and Major Businesses

　Table 35. Guangxi Xiancaotang Pharmaceutical Artemisinin Derivatives Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)

　Table 36. Guangxi Xiancaotang Pharmaceutical Artemisinin Derivatives Product

zhōngguó qīng hāo sù yǎnshēng pǐn shìchǎng fēnxī hé qūshì bàogào 2021-2027

　Table 37. Guangxi Xiancaotang Pharmaceutical Recent Developments

　Table 38. Guilin Pharmaceutical Corporation Information

　Table 39. Guilin Pharmaceutical Description and Major Businesses

　Table 40. Guilin Pharmaceutical Artemisinin Derivatives Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)

　Table 41. Guilin Pharmaceutical Artemisinin Derivatives Product

　Table 42. Guilin Pharmaceutical Recent Developments

　Table 43. Kerui Nanhai Pharmaceutical Corporation Information

　Table 44. Kerui Nanhai Pharmaceutical Description and Major Businesses

　Table 45. Kerui Nanhai Pharmaceutical Artemisinin Derivatives Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)

　Table 46. Kerui Nanhai Pharmaceutical Artemisinin Derivatives Product

　Table 47. Kerui Nanhai Pharmaceutical Recent Developments

　Table 48. Shanghai Natural Bio-engineering Co Corporation Information

　Table 49. Shanghai Natural Bio-engineering Co Description and Major Businesses

　Table 50. Shanghai Natural Bio-engineering Co Artemisinin Derivatives Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)

　Table 51. Shanghai Natural Bio-engineering Co Artemisinin Derivatives Product

　Table 52. Shanghai Natural Bio-engineering Co Recent Developments

　Table 53. Novanat Bioresource Corporation Information

　Table 54. Novanat Bioresource Description and Major Businesses

　Table 55. Novanat Bioresource Artemisinin Derivatives Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)

　Table 56. Novanat Bioresource Artemisinin Derivatives Product

　Table 57. Novanat Bioresource Recent Developments

　Table 58. Botanical Extracts EPZ Ltd Corporation Information

　Table 59. Botanical Extracts EPZ Ltd Description and Major Businesses

　Table 60. Botanical Extracts EPZ Ltd Artemisinin Derivatives Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)

　Table 61. Botanical Extracts EPZ Ltd Artemisinin Derivatives Product

　Table 62. Botanical Extracts EPZ Ltd Recent Developments

　Table 63. Artemisinin Derivatives Production Capacity (K MT) of Key Manufacturers in China Market, 2019-2021 (K MT)

　Table 64. China Artemisinin Derivatives Capacity Market Share of Key Manufacturers, 2019-2021

　Table 65. Artemisinin Derivatives Market Opportunities & Trends in China Market

　Table 66. Artemisinin Derivatives Market Drivers in China Market

　Table 67. Artemisinin Derivatives Market Restraints in China Market

　Table 68. Artemisinin Derivatives Raw Materials

　Table 69. Artemisinin Derivatives Raw Materials Suppliers in China Market

　Table 70. Typical Artemisinin Derivatives Downstream

　Table 71. Artemisinin Derivatives Downstream Clients in China Market

　Table 72. Artemisinin Derivatives Distributors and Sales Agents in China Market

List of Figures

　Figure 1. Artemisinin Derivatives Product Picture

　Figure 2. Artemisinin Derivatives Segment by Type

　Figure 3. Artemisinin Derivatives Segment by Application

　Figure 4. China Artemisinin Derivatives Market Overview: 2020

中國アルテミシニンデリバティブマーケット分析とトレンドレポート2021-2027

　Figure 5. China Artemisinin Derivatives Market Size: 2021 VS 2027 (US$, Mn)

　Figure 6. China Artemisinin Derivatives Revenue, 2016-2027 (US$, Mn)

　Figure 7. Artemisinin Derivatives Sales in China Market: 2016-2027 (K MT)

　Figure 8. The Top 3 and 5 Players Market Share by Artemisinin Derivatives Revenue in 2020

　Figure 9. Dihydroartemisinin Product Picture

　Figure 10. Artemisunate Product Picture

　Figure 11. Others Product Picture

　Figure 12. By Type - China Artemisinin Derivatives Sales Market Share, 2016-2027

　Figure 13. By Type - China Artemisinin Derivatives Revenue Market Share, 2016-2027

　Figure 14. By Type - China Artemisinin Derivatives Price (USD/MT), 2016-2027

　Figure 15. Malaria Treatment

　Figure 16. Scientific Research

　Figure 17. Others

　Figure 18. By Application - China Artemisinin Derivatives Sales Market Share, 2016-2027

　Figure 19. By Application - China Artemisinin Derivatives Revenue Market Share, 2016-2027

　Figure 20. By Application - China Artemisinin Derivatives Price (USD/MT), 2016-2027

　Figure 21. Sanofi Artemisinin Derivatives Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

　Figure 22. KPC Pharmaceuticals Artemisinin Derivatives Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

　Figure 23. Guangxi Xiancaotang Pharmaceutical Artemisinin Derivatives Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

　Figure 24. Guilin Pharmaceutical Artemisinin Derivatives Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

　Figure 25. Kerui Nanhai Pharmaceutical Artemisinin Derivatives Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

　Figure 26. Shanghai Natural Bio-engineering Co Artemisinin Derivatives Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

　Figure 27. Novanat Bioresource Artemisinin Derivatives Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

　Figure 28. Botanical Extracts EPZ Ltd Artemisinin Derivatives Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

　Figure 29. China Artemisinin Derivatives Production Capacity (K MT), 2016-2027

　Figure 30. Artemisinin Derivatives Industry Value Chain

　Figure 31. Marketing Channels

　　http://www.htout.com/0/93/China-Artemisinin-Derivatives-Market-Analysis-and-Trends-Report-2021-2027.html

　　產(chǎn)業(yè)調(diào)研網(wǎng)

　　…